BMRN
Biomarin·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
BMRN fundamentals
Biomarin (BMRN) released its earnings on Oct 27, 2025: revenue was 776.00M (YoY +4.02%), missed estimates; EPS was 0.12 (YoY -86.81%), missed estimates.
Revenue / YoY
776.00M
+4.02%
EPS / YoY
0.12
-86.81%
Report date
Oct 27, 2025
BMRN Earnings Call Summary for Q3,2025
- Revenue Growth: 11% YTD increase, driven by Enzyme Therapies (+8%) and VOXZOGO (+24%).
- Strategic Shift: Divesting ROCTAVIAN to focus on high-growth Skeletal Conditions and Enzyme Therapies.
- Financial Strength: $728M operating cash flow YTD, $2B cash balance, and 26-27% non-GAAP margin guidance.
- Pipeline Momentum: BMN 333 Phase II/III for DMD, hypochondroplasia data H1 2026, and global VOXZOGO expansion.
EPS
Revenue
Revenue & Expenses
BMRN has released its 2025 Q3 earnings report, with revenue of 776.13M, reflecting a YoY change of 4.08%, and net profit of -30.74M, showing a YoY change of -128.98%. The Sankey diagram below clearly presents BMRN's revenue sources and cost distribution.
Key Indicators
Biomarin (BMRN) key financial stats and ratios, covering profitability, financial health, and leverage.
Biomarin (BMRN)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Biomarin (BMRN)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Biomarin (BMRN)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Biomarin (BMRN) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Biomarin (BMRN) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
Did Biomarin beat or miss consensus estimates last quarter?What is the revenue and EPS growth rate for Biomarin year over year?What guidance did Biomarin's management provide for the next earnings period?What is Biomarin's gross profit margin?What were the key takeaways from Biomarin’s earnings call?What were the key takeaways from Biomarin's earnings call?What factors drove the changes in Biomarin's revenue and profit?What is the market's earnings forecast for Biomarin next quarter?
